High-dose melphalan-autologous hematopoietic cell transplantation in systemic AL amyloidosis following daratumumab-based frontline therapy

被引：2
|
作者：
Mellgard, George S. [1 ]
Bhutani, Divaya [2 ]
Mapara, Markus Y. [2 ]
Maurer, Mathew S. [3 ]
Radhakrishnan, Jai [4 ]
Lentzsch, Suzanne [2 ]
Chakraborty, Rajshekhar [2 ]
机构：
[1] Columbia Univ, Dept Med, Irving Med Ctr, New York, NY USA
[2] Columbia Univ, Herbert Irving Comprehens Canc Ctr, New York, NY 10032 USA
[3] Columbia Univ, Div Cardiol, Irving Med Ctr, New York, NY USA
[4] Columbia Univ, Div Nephrol, Irving Med Ctr, New York, NY USA
来源：
BONE MARROW TRANSPLANTATION | 2024年 / 59卷 / 08期
关键词：
LIGHT-CHAIN AMYLOIDOSIS; DEXAMETHASONE; INHIBITOR;
D O I：
10.1038/s41409-024-02301-7
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：1181 / 1183
页数：3
相关论文
共 50 条
  • [41] High-dose melphalan and stem cell transplantation in systemic AL amyloidosis in the era of novel anti-plasma cell therapy: a comprehensive review
    Cindy Varga
    Raymond L. Comenzo
    Bone Marrow Transplantation, 2019, 54 : 508 - 518
  • [42] Bortezomib and high-dose melphalan with stem cell transplantation for AL amyloidosis: a pilot study
    Sanchorawala, V.
    Quillen, K.
    Sloan, J. M.
    Andrea, N. T.
    Finn, K. T.
    Seldin, D. C.
    AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS, 2010, 17 : 186 - 186
  • [43] Hematologic relapse in AL amyloidosis after high-dose melphalan and stem cell transplantation
    Browning, Sabrina
    Quillen, Karen
    Sloan, J. Mark
    Doros, Gheorghe
    Sarosiek, Shayna
    Sanchorawala, Vaishali
    BLOOD, 2017, 130 (11) : 1383 - 1386
  • [44] High-dose melphalan and stem cell transplantation in systemic AL amyloidosis in the era of novel anti-plasma cell therapy: a comprehensive review
    Varga, Cindy
    Comenzo, Raymond L.
    BONE MARROW TRANSPLANTATION, 2019, 54 (04) : 508 - 518
  • [45] High-dose melphalan and autologous stem-cell transplantation in patients with AL amyloidosis: An 8-year study
    Skinner, M
    Sanchorawala, V
    Seldin, DC
    Dember, LM
    Falk, RH
    Berk, JL
    Anderson, JJ
    O'Hara, C
    Finn, KT
    Libbey, CA
    Wiesman, J
    Quillen, K
    Swan, N
    Wright, DG
    ANNALS OF INTERNAL MEDICINE, 2004, 140 (02) : 85 - 93
  • [46] Successful treatment of AL amyloidosis with high-dose melphalan and autologous stem cell transplantation in patients over age 65
    Seldin, David C.
    Anderson, Jennifer J.
    Skinner, Martha
    Malek, Karim
    Wright, Daniel G.
    Quillen, Karen
    Finn, Kathleen
    Oran, Betul
    Sanchorawala, Vaishali
    BLOOD, 2006, 108 (12) : 3945 - 3947
  • [47] Erratum: Tandem cycles of high-dose melphalan and autologous stem cell transplantation increases the response rate in AL amyloidosis
    V Sanchorawala
    D G Wright
    K Quillen
    K T Finn
    L M Dember
    J L Berk
    G Doros
    C Fisher
    M Skinner
    D C Seldin
    Bone Marrow Transplantation, 2007, 40 (6) : 607 - 607
  • [48] Modified High-Dose Melphalan and Autologous Stem Cell Transplantation for Immunoglobulin Light Chain Amyloidosis
    Nguyen, Vina P.
    Landau, Heather
    Quillen, Karen
    Brauneis, Dina
    Shelton, Anthony C.
    Mendelson, Lisa
    Rahman, Hafsa
    Sloan, J. Mark
    Sarosiek, Shayna
    Sanchorawala, Vaishali
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2018, 24 (09) : 1823 - 1827
  • [49] Treatment of AL cardiac amyloidosis with intravenous high-dose melphalan and stem cell transplantation
    Chung, JN
    Sanchorawala, V
    Skinner, M
    Falk, RH
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2002, 39 (05) : 136A - 136A
  • [50] High-Dose Melphalan and Stem Cell Transplantation for Patients with AL Amyloidosis and Cardiac Involvement
    Girnius, Saulius
    Seldin, David C.
    Quillen, Karen
    Andrea, Nancy T.
    Sloan, John Mark
    Berk, John L.
    Ruberg, Frederick L.
    Meier-Ewert, Hans
    Sanchorawala, Vaishali
    BLOOD, 2011, 118 (21) : 896 - 896
12345